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The tumor suppressor protein p53 is a well-known transcription factor that functions as a critical component of the genotoxic 
stress response via regulating the expression of effector proteins that control cellular fate following DNA damage. The human 
p300/CBP-associated factor (PCAF)-containing histone acetyltransferase (HAT) complex is important for the stability and activity of 
p53 via its acetylation. The human homolog of yeast alteration/deficiency in activation 2a (ADA2a) is a stable component of the 
human PCAF-containing HAT complex. In this study, we demonstrated that p53 and hADA2a physically interact with each other 
in human HEK 293T cells. Using overexpression and small interfering RNA-mediated knockdown, we demonstrated that 
hADA2a stabilizes p53 via promoting its acetylation at lysine 320 — a PCAF-dependent acetylation site. Furthermore, hADA2a 
can potentiate the transcriptional activity of p53 at the BAX and p21 promoters to induce cell apoptosis and cell cycle arrest. 
Overall, our results establish that hADA2a, a component of the PCAF-containing histone acetyltransferase co-activator complex, 
is a mediator of acetylation-dependent stabilization and activation of p53 in mammalian cells. 
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The p53 tumor suppressor protein is a sequence-specific, 
DNA-binding transcription factor. In unstressed cells, p53 is 
maintained at a very low level, but it is rapidly stabilized 
and activated during periods of cellular stress, such as that 
induced by DNA damage. This results in the activation of 
multiple cellular processes including apoptosis and cell cy-
cle checkpoints, via specific binding of p53 to the promoters 
of its target genes [1‒4]. It has become clear that a cascade 
of post-translational modification, such as phosphorylation, 
ubiquitination, and acetylation, is required to stabilize p53 
[5]. Acetylation of p53 provides a particularly important 
mechanism to control p53 stability as well as its activity 
[3,6]. p53 deacetylation by overexpression of histone 
deacetylase-associated proteins compromises its ability to  
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induce cell cycle arrest and apoptosis [7]. In contrast, inhi-
bition of p53 deacetylation increased p53’s half-life and 
activity, suggesting that acetylation might play an important 
role in the turnover of the p53 protein [8]. The acetylation 
of p53 is dependent on the activity of the p300/CBP-asso- 
ciated factor (PCAF)-containing histone acetyltransferase 
(HAT) complex, which acetylates p53 at lysine K317R No- 
tably, analysis of knock-in mice with a missense mutation 
(K317R) in the PCAF has suggested a negative regulatory 
role for the PCAF-dependent K317 (K320 in human p53) 
acetylation site [9,10]. 
The PCAF-containing complex consists of more than 20 
distinct polypeptides, including the transcriptional adaptor 
ADA2a. The ADA (human homolog of yeast altera-
tion/deficiency in activation) genes (encoding ADA1, 
ADA2, ADA3/NGG1, general control non-derepressible 5 
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(GCN5)/ADA4, and SPT20/ADA5) were genetically de-
fined in the yeast Saccharomyces cerevisiae [11]. Yeast 
ADA proteins play a role in transcriptional initiation site 
selection, interact with basal transcription factors, and fa-
cilitate the acetylation of nucleosomal histones as compo-
nents of ADA/GCN5 HAT complexes, which have multiple 
and distinct functions leading to gene-specific transcrip-
tional activation [12]. It has been suggested that ADA2 
plays an essential role in these complexes by participating 
in the recruitment of basal transcription factors, stabilizing 
the interactions with acidic activation domains, and poten-
tiating the HAT activity of GCN5 [13‒15]. Recently, sev-
eral groups have reported that the Drosophila genome con-
tains 2 distinct genes encoding ADA2 homologs: ADA2a 
and ADA2b. Biochemical characterization of the 2 ADA2 
proteins demonstrated that both interact with the HAT/ 
GCN5 complex and participate in transcriptional activation 
[16]. However, functional differences between the 2 human 
ADA2 proteins, hADA2a and hADA2b, have been recently 
reported [17]. hADA2a, but not hADA2b, was shown to be 
a stable component of the human PCAF-con- taining HAT 
complex. However, it is still unclear how hADA2a func-
tions in the PCAF-containing complex affect the transcrip-
tional activity of p53. 
In this study, we demonstrated that hADA2a physically 
interacted with p53 using coimmunoprecipitation (co-IP) 
and glutathione-S-transferase (GST) pull-down of overex-
pressed hADA2. Furthermore, given the ability of the 
hADA2a-containing PCAF complex to acetylate p53, we 
identified an important role for hADA2a in p53 acetylation, 
p53 stability, and p53 transcriptional activation following 
DNA damage, using hADA2a overexpression and small 
interfering RNA (siRNA)-mediated knockdown of endoge-
nous hADA2a. These studies underscore the role of 
hADA2a in regulating p53 function. 
1  Materials and methods 
1.1  Antibodies 
Monoclonal antibodies against p53 (DO1) and green fluo-
rescent protein (GFP) were purchased from Medical & 
Biological Laboratories Co., Ltd. (Naka-ka Nagoya, Japan), 
anti-acetylated p53 (K320) antiserum was obtained from 
Alpha Diagnostic (San Antonio, TX), a polyclonal antibody 
against p53 and a monoclonal antibody against p21 were 
purchased from Santa Cruz Biotechnology, Inc. (Santa 
Cruz, CA). Anti-GST and anti-β-actin antibodies were from 
Sigma (St. Louis, MO), the anti-hADA2a antibody was 
from Novus Biologicals (Littleton, CO), and IRDye™ 
800-conjugated secondary antibodies against mouse IgG, 
rabbit IgG, streptavidin, or GFP were purchased from 
LI-COR Bioscience (Lincoln, NE). The acetyl-histone anti- 
body sampler kit was purchased from Cell Signaling Tech-
nology (Lrvine, CA). 
1.2  Cell lines and transfections 
The human embryonic kidney cell line HEK 293T, a kind 
gift from Prof. Matsuda T., Japan) and the human osteosar-
coma epithelial cell line U-2 OS (from ATCC) cells were 
maintained in Dulbecco’s modified Eagle’s medium (Invi-
trogen) supplemented with 10% fetal bovine serum (Bio-
chrom, Berlin, Germany) and L-glutamine (2 mmol/L) at 
37°C in a humidified 5% CO2 atmosphere. DNA transfec-
tion was performed using VigoFect (Vigorous, USA), a 
non-liposomal cationic formula, according to the manufac-
turer’s instructions, or by electroporation with a single pulse 
of 120 V, 20 ms, with 10 μg plasmid/106 cells in 2-mm gap 
cuvettes using an ECM 830 Square Wave Electroporation 
System (BTX, USA). 
1.3  Immunoprecipitation (IP), GST pull-down and 
immunoblotting 
HEK 293T cells were transfected with different plasmids. 
The cells were harvested 36 h later and cell lysates were 
prepared with RIPA buffer (50 mmol/L HEPES pH 7.4, 50 
mmol/L NaCl, 2 mmol/L EDTA, 2 mmol/L EGTA, 0.1% 
SDS, 1% NP-40, with freshly added protease inhibitor 
cocktail (Roche). Cell lysates were precleared with 15 μL of 
protein G beads (sigma, USA) (50% slurry) for 1 h at 4°C. 
For IP, 2 mg of precleared supernatant was incubated with 1 
μg of antibody for 2 h with occasional rocking. Next, 20 μL 
of protein G beads were added to the above samples and 
rocked for an additional 2 h at 4°C. The beads were washed 
5 times with RIPA buffer, and the bound proteins were 
eluted and boiled with sample buffer. The supernatants were 
subjected to SDS-polyacrylamide gel electrophoresis 
(PAGE) and immunoblotting, as described previously [18]. 
The protein bands were visualized using an IRDye™ 
800-conjugated secondary antibody; signals were detected 
on an Odyssey Infrared Imager (Li-COR Bioscience). 
For GST pull-down, the GST-p53 and GST plasmids 
were transformed into E. coli strain BL21 (DE3). Expres-
sion of the fusion protein was induced by the addition of 
isopropyl β-D-1-thiogalactopyranoside to a final concentra-
tion of 1 mmol/L, and incubation at 37°C for 3 h. After lysis 
of the bacterial cells with lysozyme, GST or GST-p53 fu-
sion protein was immobilized on glutathione-Sepharose 
beads (Amersham) according to the manufacturer’s instruc-
tions. The beads were washed five times with ice-cold 
phosphate-buffered saline (PBS). The hADA2a protein was 
translated in vitro from the hADA2a-myc plasmid and la-
beled with biotin using a TNT T7 Quick Coupled transcrip-
tion/translation system (Promega, USA). Fifty microliters of 
the product were incubated with the beads at 4°C overnight. 
The beads were washed 6 times with ice-cold PBS, and then 
the bound protein was subjected to SDS-PAGE followed by 
immunoblotting with appropriate antibodies. 
 Huang J, et al.   Chinese Sci Bull   February (2011) Vol.56 No.4-5 399 
1.4  Immunofluorescence 
U-2 OS cells were plated on glass coverslips, then after 24 h 
they were fixed in PBS supplemented with 4% paraformal-
dehyde for 10 min at 4°C, and permeabilized in PBS sup-
plemented with 0.1% Triton X-100 for 30 min. After a 
30-min incubation in blocking buffer (2% bovine serum 
albumin in PBS), the cells were incubated with rabbit 
anti-p53 and mouse anti-hADA2a antibodies at 4°C over-
night, then incubated with DyLight 488-conjugated goat 
anti-rabbit IgG and TRITC-labeled anti-mouse IgG (Jack-
son ImmunoResearch Laboratories, Inc, West Grove, PA, 
USA) for 1 h. 4′,6-diamidino-2-phenylindole (DAPI; Sigma) 
was used to counterstain the nuclei. After several washing 
steps by 0.01 mol/L PBS, the cells were observed under a 
Zeiss LSM 510 Meta system (Zeiss, Germany). 
1.5  RNA interference and real-time polymerase chain 
reaction analysis 
A specific siRNA against hADA2a (si-hADA2a; target se-
quence 5′-GAAUACAGGACAGCAGGCA-3′) was chemi-
cally synthesized and PAGE-purified free of RNase con-
tamination according to the manufacturer’s instructions 
(Genechem Corporation, China). The non-silencing, control 
siRNA (si-NON) was confirmed to have no matches in the 
human genome by a BLAST search at the National Center 
for Biotechnology Information (www.ncbi.nlm.nih.gov). 
All siRNAs were dissolved to a concentration of 20 mmol/L 
in buffer containing 20 mmol/L KCl, 6 mmol/L HEPES  
pH 7.5 and 0.2 mmol/L MgCl2. U-2 OS cell density was 
adjusted to 1×106/300 μL and the indicated amount of 
siRNA was electroporated into cells. Total RNA was ex-
tracted using Trizol reagent (Life Technologies, Inc.). cDNAs 
were synthesized using a reverse transcriptase cDNA synthe-
sis kit (Fermentas, Canada) with total RNA as the template. 
The cDNA were then subjected to reverse-transcription po-
lymerase chain reaction (PCR) and real-time PCR analysis. 
The PCR primers used in this study were as follows: 
hADA2a forward: 5′-GCTCTGAAGATGGCTGTGGT-3′ 
and hADA2a reverse: 5′-CTTGGAGCCTCTTGATTTC-3′; 
p53 forward: 5′-CTGCTCAGATAGCGATGGTC-3′ and 
p53 reverse: 5′-CAGCTCTCGGAACATCTCG-3′; p21 
forward: 5′-CCCGTGAGCGATGGAAC-3′ and p21 re-
verse: 5′-CGGCGTTTGGAGTGGTAG-3′. For the internal 
control glyceraldehyde-3-phosphate dehydrogenase (GAP- 
DH) primers, the forward primer was 5′-CCACCCATGG- 
CAAATTCCATGGCA-3′ and the reverse primer was 5′-T- 
CTAGACGGCAGGTCAGGTCAGGTCCACC-3′. PCR pr- 
oducts were separated by 1.0% agarose gel electrophoresis 
and visualized by ethidium bromide staining. 
1.6  Analysis of p53 stability 
For the in vivo p53 degradation assay, 80%–90% confluent 
cultures of U-2 OS cells transfected transiently with 
hADA2a or si-hADA2a were incubated with cycloheximide 
(100 μg/mL). After 30, 60 or 90 min, the cells were har-
vested and immunoblotted using the anti-p53 antibody 
(DO-1). The intensity of the bands was quantified by densi-
tometry. 
1.7  In vivo acetylation assay 
Cells were washed twice with ice-cold PBS and then grown 
in complete medium supplemented with the deacetylase 
inhibitor trichostatin A (TSA; Sigma) at a final concentra-
tion of 10 mmol/L. Four hours after the addition of TSA, 
cells were washed twice with ice-cold PBS and lysed on ice 
in ice-cold lysis buffer (50 mmol/L Tris pH 8.0, 300 
mmol/L NaCl, 10 mmol/L MgCl2, 2.5 mmol/L CaCl2, 0.4% 
NP-40,) supplemented with 5 μmol/L TSA and protease 
inhibitor cocktail (Roche (China) Ltd). To detect acetylated 
human p53, equal amounts of cell lysates (250–500 μg pro-
tein) were incubated with 1 μg of protein G agarose-immo- 
bilized antibody specific to human p53 (DO-1) for 2 h at 
4°C. The amount of p53 in the immunoprecipitate was es-
timated by western blotting using a rabbit polyclonal 
anti-p53 antibody. To determine the acetylation status of 
p53 in these cells, the same immunoprecipitates, normalized 
for the level of p53, were subjected to SDS-PAGE. Acety-
lated p53 was detected with rabbit anti-acetylated p53 
(K320) antiserum by Western blotting. 
1.8  Reporter gene assay 
The luciferase reporter plasmid containing p21 binding sites 
(p21-Luc; Stratagene) and internal control pRL-TK (HSV- 
thymidine kinase promoter, Promega) were co-transfected 
with the hADA2a plasmid or the specific si-hADA2a de-
scribed above. Forty hours later, cells were assayed for 
luciferase activity. Luciferase activity was measured using 
the Luciferase Assay System (Vigorous, USA) according to 
the manufacturer’s protocol. 
1.9  Flow cytometry 
Phosphatidylserine externalization analysis was performed 
as described previously [19]. Briefly, transfected cells 
(2×105) were trypsinized, washed twice with PBS, and re-
suspended in 200 μL binding buffer (10 mmol/L HEPES pH 
7.4, 140 mmol/L NaCl, 1 mmol/L MgCl2, 5 mmol/L KCl, 
2.5 mmol/L CaCl2). Fluorescein isothiocyanate-conjugated 
Annexin V (Beijing Biosea, China) was added to a final 
concentration of 0.5 μg/mL. After incubation for 30 min at 
room temperature, propidium iodide (PI) was added at 1 
μg/mL, and the samples were immediately analyzed on a 
FACSCalibur flow cytometer (Becton Dickinson, San Jose, 
CA). 
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For cell cycle analysis, transfected U-2 OS cells (5×105) 
were fixed in 70% (v/v) ethanol overnight at 4°C. After 
washing with PBS, cells were incubated with RNase A (0.5 
mg/mL; Sigma) at 37°C for 30 min. Finally, after staining 
with PI (50 μg/mL), the DNA content per cell was mea-  
sured using the CellQuest Pro program on the FACSCalibur 
flow cytometer (Becton Dickinson), and the data were ana-
lyzed using ModFit software. 
2  Results 
2.1  hADA2a interacts with p53 
To confirm the interaction of hADA2a and p53 in mam-
malian cells, Flag-p53 and hADA2a-GFP plasmids were 
co-transfected into HEK 293T cells. After 30 h, the cell 
lysates were subjected to IP with an anti-GFP antibody. 
Western blotting revealed that Flag-p53 co-immunopre- 
cipitated with hADA2a-GFP (Figure 1(a)), demonstrating 
that the two proteins exist in a complex in HEK 293T cells. 
We further investigated the binding of hADA2a to p53 
by GST pull-down assays. As expected, the full-length form 
of hADA2a, generated and labeled with biotin using in vitro 
transcription/translation, was pulled down by a recombinant 
GST-p53 fusion protein (Figure 1(b)). In contrast, the control  
GST protein showed no interaction. 
To confirm the hADA2a-p53 association, we performed 
co-localization assays. U-2 OS cells were plated for 24 h, 
then treated with or without UV irradiation (20 J/m2) to in-
duce DNA damage, and incubated with mouse anti- 
hADA2a and rabbit anti-p53 antibodies. As shown previ-
ously, the same nuclear localization of endogenous ADA2a 
was detected in U-2 OS cells without UV irradiation as that 
in HEK 293T cells [20]. Moreover, hADA2a and p53 partly 
co-localized and showed a relatively diffuse nuclear distri-
bution pattern in U-2 OS cells with or without UV irradia-
tion (Figure 1(c)). All the above results support our findings 
of interaction between hADA2a and p53. 
2.2  Ectopic hADA2a expression stabilizes p53 
Because hADA2a bound to p53, we assessed whether 
hADA2a influenced endogenous p53 at the mRNA or pro-
tein level. The hADA2a-GFP plasmid was transfected into 
U-2 OS cells, and then parallel samples were processed for 
RT-PCR and western blotting. RT-PCR showed that the 
mRNA level of p53 remained unchanged, similar to that of 
the housekeeping gene GAPDH used as a loading control 
(Figure 2(a)). Western blotting indicated that overexpres-
sion of hADA2a increased p53 protein levels (Figure 2(b)).  
 
Figure 1  hADA2a directly interacts with p53. (a) Co-immunoprecipitation of hADA2a and p53 in HEK 293T cells. Cells were co-transfected with 
Flag-p53 and hADA2a-GFP or GFP alone as a control. Total cell extracts were immunoprecipitated using an anti-GFP antibody as indicated. Immunopre-
cipitated (IP) proteins were analyzed for the presence of p53 by immunoblotting (IB), using IRDye™ 800-conjugated antibody against GFP to detect the 
immunoprecipitated hADA2a-GFP, or GFP proteins as the transfection control. (b) GST pull-down assay of hADA2a and GST-p53. Biotin-labeled hADA2a 
protein generated by in vitro transcription/translation was pulled down by GST-p53 fusion protein and GST protein. Proteins pulled down were analyzed for 
biotin-labeled hADA2a using IRDye™ 800-conjugated antibody against streptavidin. One microliter of labeled translated hADA2a protein, 1 μg of GST-p53 
fusion protein or 1 μg of GST protein were used as input. (c) hADA2a partly colocalized with p53 in U-2 OS cells treated with or without UV irradiation (20 
J/m2, 12 h). Immunofluorescence was performed as described. Endogenous hADA2a expression was detected with mouse anti-hADA2a antibody followed 
by TRITC-labeled anti-mouse secondary antibody; endogenous p53 was detected by rabbit anti-p53 antibody followed by DyLight 488-conjugated 
anti-rabbit secondary antibody. Cell nuclei were stained with DAPI. 
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Figure 2  hADA2a stabilizes p53 protein by post-translational modifica-
tion. U-2 OS cells were transfected with the indicated plasmids for 48 h. 
Cells were then harvested for protein or mRNA analysis. (a) U-2 OS cells 
were analyzed to detect the levels of p53, p21, or GAPDH (loading control) 
by real-time PCR. Data are presented as the mean ± SD. **, P < 0.01. (b) 
Equal amounts of whole cell extracts were immunoblotted using anti-p53, 
anti-p21, or anti-β-actin antibodies. (c) hADA2a overexpression extended 
the half-life of p53. The transfected cells were treated with cycloheximide 
(CHX; 100 μg/mL) and harvested at the indicated times. Cell lysates were 
analyzed by immunoblotting using anti-p53 or anti-β-actin antibodies. (d) 
The intensity of p53 relative to β-actin was quantified by densitometry 
using Li-Cor Odyssey software, and plotted against the time of cyclo-
heximide treatment. 
In contrast, p21, a protein functionally downstream of p53, 
was significantly increased at both the mRNA and the pro-
tein levels (Figure 2(a) and (b)). These observations indicate 
that the accumulation of p53 protein upon hADA2a overex-
pression was likely because of post-translational modifica-
tion. 
To investigate whether the hADA2a-dependent increase 
in p53 protein reflected an increase in its stability, we as-
sessed the half-life of p53 following a cycloheximide block 
of new protein synthesis. U-2 OS cells were transfected 
with hADA2a-GFP or GFP alone. The transfected cells 
were incubated with cycloheximide, and the level of p53 
was assessed by immunoblotting. As shown in Figure 2(c) 
and (d), overexpression of hADA2a resulted in a slower loss 
of p53 signal compared with that in cells without hADA2a 
overexpression. This suggests that ectopic hADA2a expres-
sion stabilizes endogenous p53. 
2.3  siRNA-mediated depletion of hADA2a destabilizes 
p53 
To test the role of hADA2a in stabilizing p53, a specific 
siRNA for hADA2a was designed to silence the expression  
of endogenous hADA2a in U-2 OS cells. We found that 
hADA2a mRNA and protein levels were significantly de-
creased in cells transfected with si-hADA2a (Figure 3(a)). 
As illustrated in Figure 3(b) and (c), endogenous p53 pro-
tein, but not p53 mRNA, was significantly decreased. 
Moreover, p21 was also decreased at both the mRNA and 
protein levels. 
We next assessed the half-life of p53 protein after 
si-hADA2a transfection. As shown in Figure 3(d) and (e), 
we determined that depletion of endogenous hADA2a was 
associated with a slight acceleration in p53 decay. This 
suggests that the decrease in p53 protein after hADA2a 
knockdown was because of destabilization of the p53 protein. 
2.4  hADA2a affects the level of p53 by participating in 
the PCAF complex 
To determine the role of hADA2a in the PCAF complex, we  
 
Figure 3  Transient knockdown of hADA2a expression decreases the 
level of endogenous p53. U-2 OS cells were transfected with specific 
siRNA against hADA2a (si-hADA2a), control siRNA (si-NON) or siRNA 
against GAPDH (si-GAPDH). Cells were harvested at different time points 
for protein or mRNA analysis. (a) RT-PCR results for hADA2a mRNA 
expression and immunoblotting results for hADA2a protein expression. 
si-hADA2a showed a strong inhibitory effect on hADA2a mRNA and 
protein expression in U-2 OS cells 60 h after transfection with si-hADA2a 
compared with si-NON. (b) Total RNAs were analyzed by real-time PCR 
to detect the levels of p53, p21, or GAPDH as a loading control. Data are 
presented as the mean ± SD. *, P < 0.05. (c) Equal amounts of protein from 
cell lysates were subjected to immunoblotting using anti-p53, anti-p21, or 
anti-β-actin antibodies. (d) Knockdown of endogenous hADA2a acceler-
ated the decay of endogenous p53. Transfected cells were treated with 
cycloheximide (100 μg/mL) and harvested at the indicated times. Total cell 
lysates were analyzed for the presence of p53 by immunoblotting. (e) Rela-
tive p53 protein levels were quantified by densitometry against β-actin 
using Li-Cor Odyssey software and plotted against the time of cyclo-
heximide treatment. 
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first tested the interaction between hADA2a and PCAF us-
ing co-IP. After transient transfection in HEK 293T cells 
with pCMV-Tag2B-PCAF (Flag-tagged) and hADA2a- 
GFP, the proteins were immunoprecipitated with anti-Flag 
or anti-GFP antibody, followed by western blotting with 
anti-GFP or anti-Flag antibody. As shown in Figure 4(a), a 
specific band corresponding to hADA2a or PCAF was ob-
served in cell lysates co-transfected with pCMV-Tag2B- 
PCAF or hADA2a-GFP, whereas no band was observed in 
the cell lysates transfected with the empty vector (negative 
control). This confirmed the interaction between PCAF and 
hADA2a. 
To address whether hADA2a promotes acetylation of 
p53 at K320, U-2 OS cells were transfected with the 
hADA2a plasmid or si-hADA2a. After 24 h, the transfected 
cells were UV irradiated at 20 J/m2 for 16 h to induce DNA 
damage, and then the levels of acetylated p53 were detected 
using IP and immunoblotting. As illustrated in Figure 4(b), 
the levels of acetylated p53 at K320 were significantly 
higher in cells overexpressing hADA2a (P < 0.05), and sig-
nificantly lower in cells transfected with si-hADA2a (P < 
0.05). 
2.5  hADA2a potentiates p53-induced apoptosis 
We next investigated whether hADA2a was required for 
apoptosis induced by DNA damage. U-2 OS cells were 
transfected with either pcDB-hADA2a or si-hADA2a, and 
then were treated with 20 J/m2 of UV irradiation. After 24 h, 
apoptosis was monitored by caspase-mediated poly (ADP- 
ribose) polymerase (PARP) cleavage and BAX expression 
by western blotting. Overexpressed hADA2a increased 
PARP cleavage and BAX expression compared with the 
vector control, independent of UV irradiation (Figure 5(a)).  
In contrast, si-hADA2a inhibited PARP cleavage and BAX 
expression slightly after UV irradiation (Figure 5(b)). 
Apoptotic cells were also assessed by Annexin-V/PI la-
beling flow cytometry. As shown in Figure 5(c), overex-
pression of hADA2a alone significantly induced apoptosis, 
showing a 20% increase compared with the control plasmid 
(P<0.05). However, we did not observe a synergistic effect 
between hADA2a overexpression and UV irradiation. 
si-hADA2a slightly reduced UV-triggered apoptosis. 
2.6  hADA2a increases p53-mediated transactivation of 
p21 and induces a cell cycle checkpoint 
We determined whether hADA2a influences p53 activity in 
promoting p21 expression in U-2 OS cells. U-2 OS cells 
were transiently co-transfected with the hADA2a plasmid or 
si-hADA2a and a p21 luciferase reporter construct, together 
with pRL-TK, then the luciferase activity was determined. 
Overexpressed hADA2a resulted in an approximately 2-fold 
increase in p53-mediated transcriptional activation of p21 
compared with the vector control. Knockdown of endoge-
nous hADA2a strongly inhibited p53-mediated transcrip-
tional activation of p21 compared with the si-NON control 
(Figure 6(a)). We also examined whether hADA2a affected 
the cell cycle checkpoint, when cells respond to DNA dam-
age. U-2 OS cells were transfected with either pcDB- 
hADA2a or si-hADA2a. Then, they were treated with 20 J/m2 
of UV irradiation for 20 h. In response to DNA damage in-
duced by UV treatment, more hADA2a-overexpressing cells 
were in G1 than in S phase, and fewer hADA2a knockdown 
cells were in G1 than in S phase (Figure 6(b)). These results 
indicate that hADA2a might play an important role in the 
cell cycle checkpoint through p53-dependent p21 transacti-
vation in response to DNA damage. 
 
Figure 4  hADA2a participates in the PCAF complex and affects p53 acetylation. (a) Co-immunoprecipitation of hADA2a and PCAF in HEK 293T cells. 
Cells were co-transfected with Flag-PCAF and hADA2a-GFP or empty vector. Thirty-six hours after transfection, whole cell lysates were subjected to im-
munoprecipitation (IP) using anti-GFP or anti-Flag antibody as indicated. Immunoprecipitated proteins were then analyzed for the presence of PCAF or 
hADA2a by immunoblotting (IB), using IRDye™ 800-conjugated antibody against GFP to detect the immunoprecipitated hADA2a-GFP, and mouse 
anti-Flag antibody to detect the immunoprecipitated Flag-PCAF. (b) U-2 OS cells were transfected with either hADA2a-GFP, GFP alone, si-NON or 
si-hADA2a. After 24 h, the transfected cells were UV irradiated at 20 J/m2 for 16 h, cells were harvested, and equivalent amounts of cell lysates were im-
munoprecipitated using anti-p53 monoclonal antibody (DO-1). Then the immunoprecipitated proteins were analyzed for their levels of total and acetylated 
p53 using the indicated antibodies. Also, the intensity of acetylated p53 was quantitated and normalized to the total p53 signal using ImageJ software. The 
histograms show the ratios of acetylated versus total p53. 
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Figure 5  Effect of hADA2a on p53-induced apoptosis. U-2 OS cells were transfected with pcDB-hADA2a, pcDB, si-NON, or si-hADA2a. After 24 h, the 
cells were either mock-treated or treated with 20 J/m2 of UV irradiation for another 24 h. (a) and (b) Representative western blots showing the expression of 
proteins associated with apoptosis (PARP and BAX). Equal protein loading was confirmed by re-probing the membrane with β-actin. (c) Transfected U-2 
OS cells were harvested and stained with Annexin V/PI. The percentage of Annexin V- and/or PI-positive cells is shown. Annexin V- (x-axis) and PI- (y-axis) 
double negative cells are viable. Annexin V-positive and PI-weakly positive cells are apoptotic (they have an increased cell membrane permeability), 
whereas Annexin V-positive and PI-strongly positive cells are late apoptotic/necrotic and PI-positive only cells are necrotic. The data are representative of 
three independent experiments. 
 
Figure 6  Effect of hADA2a on p53 transactivation of p21 and the cell cycle checkpoint. (a) The effect of hADA2a in activating the p21 promoter. Cells 
were co-transfected with hADA2a plasmid or si-hADA2a and a p21 luciferase reporter construct, together with pRL-TK. The data shown are relative 
luciferase activities normalized to Renilla luciferase activity, and are the means ± SD of three experiments. (b) U-2 OS cells were transfected with either 
pcDB-hADA2a, pcDB, si-NON, or si-hADA2a. After 24 h, U-2 OS cells were either mock-treated or treated with 20 J/m2 of UV irradiation for 20 h. The 
cells were then harvested, stained with propidium iodide, and subjected to flow cytometry. *, P < 0.05. 
3  Discussion 
p53 is a sequence-specific homotetrameric transcription fac-
tor involved in the transactivation of genes that are responsi-
ble for multiple cellular processes, such as apoptosis, cell 
cycle arrest, and DNA repair [21]. Accumulating evidence 
had indicated that post-translational modifications of p53, 
such as acetylation, play important roles in regulating p53 
stability and activity. The role of p53 acetylation at multiple 
C-terminal lysine resides, mediated by the co-activators  
PCAF and p300, has been extensively studied using bio-
chemistry and cell transfection assays [9]. Here, we demon-
strated an important role for hADA2a in the stabilization 
and activation of p53. We also provided evidence that the 
hADA2a-dependent regulation of p53 stability and activity 
is mediated by acetylation of p53 at K320 through partici-
pating in the PCAF complex. Furthermore, hADA2a poten-
tiated the transcriptional activity of p53 at the BAX and p21 
promoters, inducing apoptosis and cell cycle arrest. 
ADA2 was initially identified as a core component of the 
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yeast ADA co-activator complex, which associated with the 
HAT protein Gcn5 [15]. No role for ADA2 independent of 
Gcn5 has been characterized in Saccharomyces cerevisiae, 
although multiple forms of ADA2 exist in Drosophila 
melanogaster [16,22], plants [23], mice, and humans [17]. 
In Drosophila, ADA2a and ADA2b are required for normal 
development but have distinct functions [24]. Recent studies 
of ADA2a and ADA2b in higher eukaryotes, including 
mammals, have demonstrated that these proteins assemble 
into multiple complexes that vary considerably. In addition, 
hADA3 also participates in these complexes and associates 
with p53; hADA3 overexpression increases the transcrip-
tional activity of p53 by affecting p53 acetylation [25‒27]. 
Here, we showed, using Co-IP, GST pull-down, and colo-
calization assays, that hADA2a also directly interacts with 
p53. 
We found consistently that overexpression of hADA2a 
stabilized the p53 protein, while depletion of endogenous 
hADA2a was associated with a slight acceleration in p53 
decay. However, the physiological implications of this in-
teraction, and the mechanism of hADA2a-mediated regula-
tion of p53 are still unclear. Recent studies have demon-
strated that many proteins involved in transcriptional regu-
lation, including transcription factors themselves, can be 
modified by acetylation. Specifically, acetylation of p53 
provides a crucial mechanism to control its stability and 
activity. Two acetyltransferases, p300 and PCAF, have been 
implicated in promoting p53 C-terminal acetylation, which 
favors p53 stabilization [3,9]. Ogryzko et al. [28] identified 
that hADA2a was a stable component of the human PCAF- 
containing HAT complex, was involved in the acetylation 
of p53 K320 and increased the target DNA-binding affinity 
of p53. Our results showed that hADA2a did indeed par-
ticipate in the PCAF complex; moreover hADA2a affected 
acetylation of the PCAF-dependent acetylation site at K320 
in p53. We suggest that hADA2a plays a crucial role in me-
diating p53 etylation by recruiting HATs. 
We also looked for evidence that hADA2a plays a role in 
regulating p53 function and in modulating the cellular re-
sponse to DNA damage. p53 induces apoptosis via upregu-
lating several proapoptotic genes, such as BAX [29]. We 
demonstrated that overexpression of hADA2a significantly 
induced apoptosis. Furthermore, Barlev et al. [8] indicated 
that acetylation of p53 and its association with co-activators 
was required for the physiological function of p53 in cell 
cycle arrest following DNA damage. The search for media-
tors of p53-dependent cell cycle arrest has identified many 
cellular p53 target genes, including p21cip1/waf1, a well char-
acterized cyclin-dependent kinase inhibitor, which mediates 
cell cycle arrest in G1 when overexpressed [30]. Our results 
showed that hADA2a potentiated the transcriptional activity 
of p53 at the p21 promoter and led to a p53-dependent cell 
cycle arrest in response to UV irradiation. Our data indicate 
that hADA2a affects the acetylation of p53, which is re-
sponsible for the regulation of pro-apoptotic and cell cycle 
arrest-promoting gene expression after DNA damage. Thus, 
we suggest that hADA2a plays a major role in the acetyla-
tion-dependent stabilization and activity of p53. This repre-
sents a major step forward in understanding the mechanisms 
that control p53 function. 
hADA2a contains a Swi3p, Rsc8p and Moira (SWIRM) 
domain that might function to potentiate chromosomal 
structural changes necessary for the recruitment of protein 
complexes for chromatin remodeling or transcription [20]. It 
has been suggested that hADA2a is a molecular scaffold for 
the histone acetyltransferases that promotes histone lysine 
acetylation and transcriptional activation. However, it re-
mains to be determined how hADA2a interacts with p53 to 
regulate its acetylation. Further analysis of the role of 
hADA2a in the post-translational regulation of the p53 gene 
might provide mechanistic insight into the regulation of 
p53-targeted genes that contribute to cellular apoptosis and 
the cell cycle. 
In conclusion, our identification of the interaction be-
tween hADA2a and human p53, and our description of 
hADA2a as an important regulator of p53 acetylation, sta-
bility, and activity, has provided new insight into p53 biol-
ogy. Further studies of hADA2a-deficient animals and 
p53-directed HATs should help delineate the biochemical 
basis as well as the overall biological importance of 
hADA2a-dependent p53 regulation. 
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